New drug aims to stop bleeding in emergency surgeries for blood thinner users
Disease control
Not yet recruiting
This phase 3 trial tests if a single dose of VMX-C001 can safely control bleeding during urgent, high-risk surgery in 800 adults taking blood thinners (FXa DOACs). Participants receive either VMX-C001 or standard care before their procedure. The main goal is to see if bleeding co…
Phase: PHASE3 • Sponsor: VarmX B.V. • Aim: Disease control
Last updated May 12, 2026 13:41 UTC